{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:30:15Z","timestamp":1790947815736,"version":"4.1.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clare Boothe Luce Foundation"},{"DOI":"10.13039\/100009847","name":"Fordham University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11030-023-10621-x","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T05:02:43Z","timestamp":1677474163000},"page":"817-849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors"],"prefix":"10.1007","volume":"28","author":[{"given":"Saige M.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Lambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Daso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6987-9717","authenticated-orcid":false,"given":"Ipsita A.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"issue":"1","key":"10621_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3322\/caac.21203","volume":"64","author":"C DeSantis","year":"2014","unstructured":"DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64(1):52\u201362. https:\/\/doi.org\/10.3322\/caac.21203","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10621_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321(3):288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323","journal-title":"JAMA"},{"issue":"1","key":"10621_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2478\/v10019-010-0054-4","volume":"45","author":"T Ovcaricek","year":"2011","unstructured":"Ovcaricek T, Frkovic S, Matos E, Mozina B, Borstnar S (2011) Triple negative breast cancer-prognostic factors and survival. Radiol Oncol 45(1):46\u201352. https:\/\/doi.org\/10.2478\/v10019-010-0054-4","journal-title":"Radiol Oncol"},{"key":"10621_CR4","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","volume":"9","author":"CK Anders","year":"2009","unstructured":"Anders CK, Carey LA (2009) Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer 9:S73\u2013S81. https:\/\/doi.org\/10.3816\/CBC.2009.s.008","journal-title":"Clin Breast Cancer"},{"issue":"7","key":"10621_CR5","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1021\/jf0101410","volume":"49","author":"M Richelle","year":"2001","unstructured":"Richelle M, Tavazzi I, Offord E (2001) Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. J Agr Food Chem 49(7):3438\u20133442. https:\/\/doi.org\/10.1021\/jf0101410","journal-title":"J Agr Food Chem"},{"issue":"10","key":"10621_CR6","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1093\/jn\/133.10.3275S","volume":"133","author":"B Frei","year":"2003","unstructured":"Frei B, Higdon JV (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133(10):3275\u20133284. https:\/\/doi.org\/10.1093\/jn\/133.10.3275S","journal-title":"J Nutr"},{"issue":"12","key":"10621_CR7","doi-asserted-by":"publisher","first-page":"19292","DOI":"10.3390\/molecules191219292","volume":"19","author":"JD Guzman","year":"2014","unstructured":"Guzman JD (2014) Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity. Molecules 19(12):19292\u201319349","journal-title":"Molecules"},{"issue":"11","key":"10621_CR8","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.2174\/092986711795471347","volume":"18","author":"P De","year":"2011","unstructured":"De P, Baltas M, Bedos-Belval F (2011) Cinnamic acid derivatives as anticancer agents-a review. Curr Med Chem 18(11):1672\u20131703. https:\/\/doi.org\/10.2174\/092986711795471347","journal-title":"Curr Med Chem"},{"issue":"16","key":"10621_CR9","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.3390\/ijms21165712","volume":"21","author":"N Ruwizhi","year":"2020","unstructured":"Ruwizhi N, Aderibigbe BA (2020) Cinnamic acid derivatives and their biological efficacy. Int J Mol Sci 21(16):5712. https:\/\/doi.org\/10.3390\/ijms21165712","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"10621_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11010-010-0655-7","volume":"349","author":"NR Prasad","year":"2011","unstructured":"Prasad NR, Karthikeyan A, Karthikeyan S, Reddy BV (2011) Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line. Mol Cell Biochem 349(1\u20132):11\u201319. https:\/\/doi.org\/10.1007\/s11010-010-0655-7","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"10621_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/or.2016.4804","volume":"36","author":"X Zhang","year":"2016","unstructured":"Zhang X, Lin D, Jiang R, Li H, Wan J, Li H (2016) Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition. Oncol Rep 36(1):271\u2013278. https:\/\/doi.org\/10.3892\/or.2016.4804","journal-title":"Oncol Rep"},{"issue":"3","key":"10621_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ptr.4718","volume":"27","author":"CS Kong","year":"2013","unstructured":"Kong CS, Jeong CH, Choi JS, Jeong KKJ, JW, (2013) Antiangiogenic effects of p-coumaric acid in human endothelial cells. Phytother Res 27(3):317\u2013323. https:\/\/doi.org\/10.1002\/ptr.4718","journal-title":"Phytother Res"},{"issue":"2","key":"10621_CR13","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1186\/bcr752","volume":"6","author":"M Kampa","year":"2004","unstructured":"Kampa M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzoglou A, Bakogeorgou E, Kouimtzoglou E, Blekas G, Boskou D, Gravanis A, Castanas E (2004) Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res 6(2):R63\u2013R74. https:\/\/doi.org\/10.1186\/bcr752","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10621_CR14","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.3892\/or.2016.4690","volume":"35","author":"R Wang","year":"2016","unstructured":"Wang R, Ma L, Weng D, Yao J, Liu X, Jin F (2016) Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway. Oncol Rep 35(5):3075\u20133083. https:\/\/doi.org\/10.3892\/or.2016.4690","journal-title":"Oncol Rep"},{"key":"10621_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jff.2015.04.009","volume":"15","author":"B Hu","year":"2015","unstructured":"Hu B, Wang Y, Xie M, Hu G, Ma F, Zeng X (2015) Polymer nanoparticles composed with gallic acid grafted chitosan and bioactive peptides combined antioxidant, anticancer activities and improved delivery property for labile polyphenols. J Funct Foods 15:593\u2013603","journal-title":"J Funct Foods"},{"issue":"5","key":"10621_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1263\/jbb.99.448","volume":"99","author":"F Uchiyama","year":"2005","unstructured":"Uchiyama F, Tanaka Y, Minari Y, Tokui N (2005) Designing scaffolds of peptides for phage display libraries. J Biosci Bioeng 99(5):448\u2013456. https:\/\/doi.org\/10.1263\/jbb.99.448","journal-title":"J Biosci Bioeng"},{"issue":"2","key":"10621_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bmc.2015.12.020","volume":"24","author":"Y Gilad","year":"2016","unstructured":"Gilad Y, Noy E, Senderowitz H, Albeck A, Firer MA, Gellerman G (2016) Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery. Bioorg Med Chem 24(2):294\u2013303. https:\/\/doi.org\/10.1016\/j.bmc.2015.12.020","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10621_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/10611860902737920","volume":"17","author":"Y Zheng","year":"2009","unstructured":"Zheng Y, Cai Z, Song X, Chen Q, Bi Y, Li Y, Hou S (2009) Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies. J Drug Target 17(4):294\u2013303. https:\/\/doi.org\/10.1080\/10611860902737920","journal-title":"J Drug Target"},{"issue":"34","key":"10621_CR19","doi-asserted-by":"publisher","first-page":"8690","DOI":"10.1016\/j.biomaterials.2013.07.100","volume":"34","author":"C Yewale","year":"2013","unstructured":"Yewale C, Baradia D, Vhora I, Patil S, Misra A (2013) Epidermal growth factor receptor targeting in cancer: a review of trends and strategies. Biomaterials 34(34):8690\u20138707. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.07.100","journal-title":"Biomaterials"},{"issue":"1","key":"10621_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1517\/14728222.2011.538682","volume":"15","author":"M Tandon","year":"2011","unstructured":"Tandon M, Vemula SV, Mittal SK (2011) Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opin Ther Tar 15(1):31\u201351. https:\/\/doi.org\/10.1517\/14728222.2011.538682","journal-title":"Expert Opin Ther Tar"},{"issue":"18","key":"10621_CR21","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1242\/jcs.111.18.2741","volume":"111","author":"Z Nikolova","year":"1998","unstructured":"Nikolova Z, Djonov V, Zuercher G, Andres AC, Ziemiecki A (1998) Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. J Cell Sci 111(18):2741\u20132751. https:\/\/doi.org\/10.1242\/jcs.111.18.2741","journal-title":"J Cell Sci"},{"issue":"1","key":"10621_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2353\/ajpath.2006.050889","volume":"169","author":"SR Kumar","year":"2006","unstructured":"Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, Scehnet J, Kumar NG, Hawes D, Press MF, Weaver FA (2006) Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 169(1):279\u2013293. https:\/\/doi.org\/10.2353\/ajpath.2006.050889","journal-title":"Am J Pathol"},{"issue":"Pt 1","key":"10621_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1242\/jcs.115.1.25","volume":"115","author":"N Munarini","year":"2002","unstructured":"Munarini N, J\u00e4ger R, Abderhalden S, Zuercher G, Rohrbach V, Loercher S, Pfanner-Meyer B, Andres AC, Ziemiecki A (2002) Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. J Cell Sci 115(Pt 1):25\u201337. https:\/\/doi.org\/10.1242\/jcs.115.1.25","journal-title":"J Cell Sci"},{"issue":"5","key":"10621_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ccell.2015.09.008","volume":"28","author":"S Pradeep","year":"2015","unstructured":"Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY, Noh K, Pecot CV, Rupaimoole R, Stein MA, Brock S, Wen Y, Xiog C, Gharpure K, Hansen JM, Nagaraja AS, Previs RA, Vivas-Mejia P, Han HD, Hu W, Mangala LS, Zand B, Stagg LJ, Ladbury JE et al (2015) Erythropoietin stimulates tumor growth via EphB4. Cancer Cell 28(5):610\u2013622. https:\/\/doi.org\/10.1016\/j.ccell.2015.09.008","journal-title":"Cancer Cell"},{"issue":"7","key":"10621_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/sj.bjc.6603642","volume":"96","author":"SR Kumar","year":"2007","unstructured":"Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, Weaver FA (2007) The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. Brit J Cancer 96(7):1083\u20131091","journal-title":"Brit J Cancer"},{"issue":"7","key":"10621_CR26","doi-asserted-by":"publisher","first-page":"e67668","DOI":"10.1371\/journal.pone.0067668","volume":"8","author":"BD Ferguson","year":"2013","unstructured":"Ferguson BD, Liu R, Rolle CE, Tan YHC, Krasnoperov V, Kanteti R, Tretiakova MS, Cervantes GM, Hasina R, Hseu RD, Iafrate AJ, Karrison T, Ferguson MK, Husain AN, Faoro L, Vokes EE, Gill PS, Salgia R (2013) The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target. PLoS ONE 8(7):e67668. https:\/\/doi.org\/10.1371\/journal.pone.0067668","journal-title":"PLoS ONE"},{"issue":"4","key":"10621_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/dgd.12126","volume":"56","author":"P Kaenel","year":"2014","unstructured":"Kaenel P, Hahnewald S, Wotzkow C, Strange R, Andres AC (2014) Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. Dev Growth Differ 56(4):255\u2013275. https:\/\/doi.org\/10.1111\/dgd.12126","journal-title":"Dev Growth Differ"},{"issue":"9","key":"10621_CR28","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1182\/blood-2006-05-023341","volume":"108","author":"O Salvucci","year":"2006","unstructured":"Salvucci O, de la Luz SM, Martina JA, McCormick PJ, Tosato G (2006) EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling. Blood 108(9):2914\u20132922. https:\/\/doi.org\/10.1182\/blood-2006-05-023341","journal-title":"Blood"},{"issue":"1","key":"10621_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF02893405","volume":"10","author":"Q Wu","year":"2004","unstructured":"Wu Q, Suo Z, Risberg B, Karlsson MG, Villman K, Nesland JM (2004) Expression of EphB2 and EphB4 in breast carcinoma. Pathol Oncol Res 10(1):26. https:\/\/doi.org\/10.1007\/BF02893405","journal-title":"Pathol Oncol Res"},{"issue":"7","key":"10621_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrm856","volume":"3","author":"K Kullander","year":"2002","unstructured":"Kullander K, Klein R (2002) Mechanisms and functions of Eph and ephrin signaling. Nat Rev Mol Cell Bio 3(7):475\u2013486. https:\/\/doi.org\/10.1038\/nrm856","journal-title":"Nat Rev Mol Cell Bio"},{"issue":"1","key":"10621_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s1359-6101(01)00031-4","volume":"13","author":"N Cheng","year":"2002","unstructured":"Cheng N, Brantley DM, Chen J (2002) The ephrins and Eph receptors in angiogenesis. Cytokine Growth F R 13(1):75\u201385. https:\/\/doi.org\/10.1016\/s1359-6101(01)00031-4","journal-title":"Cytokine Growth F R"},{"issue":"2","key":"10621_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.yexcr.2013.10.022","volume":"320","author":"S Chukkapalli","year":"2014","unstructured":"Chukkapalli S, Amessou M, Dilly AK, Dekhil H, Zhao J, Liu Q, Bejna A, Thomas RD, Bandyopadhyay S, Bismar TA, Neill D, Azoulay L, Batist G, Kandouz M (2014) Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells. Exp Cell Res 320(2):233\u2013246. https:\/\/doi.org\/10.1016\/j.yexcr.2013.10.022","journal-title":"Exp Cell Res"},{"issue":"11","key":"10621_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-2042-y","volume":"10","author":"V Sagar","year":"2019","unstructured":"Sagar V, Vatapalli R, Lysy B, Pamarthy S, Anker JF, Rodriguez Y, Han H, Unno K, Stadler WM, Catalona WJ, Hussain M, Gill PS, Abdulkadir SA (2019) EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells. Cell Death Dis 10(11):1\u201314. https:\/\/doi.org\/10.1038\/s41419-019-2042-y","journal-title":"Cell Death Dis"},{"issue":"4","key":"10621_CR34","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2353\/ajpath.2010.090755","volume":"176","author":"V Krasnoperov","year":"2010","unstructured":"Krasnoperov V, Kumar SR, Ley E, Li X, Scehnet J, Liu R, Zozulya S, Gill PS (2010) Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth. Am J Pathol 176(4):2029\u20132038. https:\/\/doi.org\/10.2353\/ajpath.2010.090755","journal-title":"Am J Pathol"},{"key":"10621_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.semcancer.2017.10.002","volume":"56","author":"Y Chen","year":"2019","unstructured":"Chen Y, Zhang H, Zhang Y (2019) Targeting receptor tyrosine kinase EphB4 in cancer therapy. Semin Cancer Biol 56:37\u201346. https:\/\/doi.org\/10.1016\/j.semcancer.2017.10.002","journal-title":"Semin Cancer Biol"},{"issue":"38","key":"10621_CR36","doi-asserted-by":"publisher","first-page":"28185","DOI":"10.1074\/jbc.M605766200","volume":"281","author":"JE Chrencik","year":"2006","unstructured":"Chrencik JE, Brooun A, Kraus ML, Recht MI, Kolatkar AR, Gye WH, Seifert JM, Widmer H, Auer M, Kuhn P (2006) Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity. J Biol Chem 281(38):28185\u201328192. https:\/\/doi.org\/10.1074\/jbc.M605766200","journal-title":"J Biol Chem"},{"key":"10621_CR37","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.bbapap.2014.07.002","volume":"10","author":"D Dai","year":"1844","unstructured":"Dai D, Huang Q, Nussinov R (1844) Ma B (2014) Promiscuous and specific recognition among Ephrins and Eph receptors. Biochim Biophys Acta 10:1729\u20131740. https:\/\/doi.org\/10.1016\/j.bbapap.2014.07.002","journal-title":"Biochim Biophys Acta"},{"key":"10621_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/pro.2445","volume":"23","author":"RC Overman","year":"2014","unstructured":"Overman RC, Debreczeni JE, Truman CM, Mcalister MS, Attwood TK (2014) Completing the structural family portrait of the human EphB tyrosine kinase domains. Protein Sci 23:627. https:\/\/doi.org\/10.1002\/pro.2445","journal-title":"Protein Sci"},{"key":"10621_CR39","doi-asserted-by":"publisher","first-page":"e00040","DOI":"10.1042\/BSR20130028","volume":"33","author":"RC Overman","year":"2013","unstructured":"Overman RC, Debereczeni JE, Truman CM, McAlister MS, Attwood RK (2013) Biochemical and biophysical characterization of four EphB kinase domains reveals contrasting thermodynamic, kinetic and inhibition profiles. Biosci Rep 33:e00040","journal-title":"Biosci Rep"},{"key":"10621_CR40","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1111\/j.1742-4658.2009.07147.x","volume":"276","author":"TL Davis","year":"2009","unstructured":"Davis TL, Walker JR, Allali-Hassani A, Parker SA, Dhe-Paganon TBE (2009) Structural recognition of an optimized substrate for the ephrin family of receptor tyrosine kinases. FEBS J 276:4395\u20134404. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.07147.x","journal-title":"FEBS J"},{"issue":"5","key":"10621_CR41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger D, de Groot B (2010) Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. J Comput Aid Mol Des 24(5):417\u2013422. https:\/\/doi.org\/10.1007\/s10822-010-9352-6","journal-title":"J Comput Aid Mol Des"},{"issue":"4","key":"10621_CR42","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2174\/157489312803901063","volume":"7","author":"SL Azevedo","year":"2012","unstructured":"Azevedo SL, Moraes FP, Xavier MM, Pantoja E, Villavicencio B, Finck J, Proenca AM, Beiestorf RK, de Azevedo W (2012) Recent progress of molecular docking simulations applied to development of drugs. Curr Bioinform 7(4):352\u2013365. https:\/\/doi.org\/10.2174\/157489312803901063","journal-title":"Curr Bioinform"},{"issue":"1","key":"10621_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/prot.10504","volume":"54","author":"DM Smith","year":"2004","unstructured":"Smith DM, Daniel KG, Wang Z, Guida WC, Chan TH, Dou QP (2004) Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design. Proteins 54(1):58\u201370. https:\/\/doi.org\/10.1002\/prot.10504","journal-title":"Proteins"},{"issue":"1","key":"10621_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bjbas.2017.08.004","volume":"7","author":"MG Sunagar","year":"2018","unstructured":"Sunagar MG, Aravind P, Gaonkar S, Devaraju KS, Joshi SD, Dixit SR, Harish BM, Khazi IAM (2018) In silico binding affinity studies of N-9 substituted 6-(4-(4-propoxyphenyl) piperazin-1-yl)-9H-purine derivatives -Target for P70\u2013S6K1 & PI3K-\u03b4 kinases. Beni-Suef Univ J Basic Appl Sci. 7(1):84\u201391. https:\/\/doi.org\/10.1016\/j.bjbas.2017.08.004","journal-title":"Beni-Suef Univ J Basic Appl Sci."},{"issue":"16","key":"10621_CR45","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/cmdc.201800398","volume":"13","author":"A Tr\u00f6ster","year":"2018","unstructured":"Tr\u00f6ster A, Heinzlmeir S, Berger BT, Gande SL, Saxena K, Sreeramulu S, Linhard V, Nasiri AH, Bolte M, M\u00fcller S, Kuster B, Medard G, Kudlinzki D, Schwalbe H (2018) NVP-BHG712: effects of regioisomers on the affinity and selectivity toward the EPHrin Family. ChemMedChem 13(16):1629\u20131633. https:\/\/doi.org\/10.1002\/cmdc.201800398","journal-title":"ChemMedChem"},{"issue":"7","key":"10621_CR46","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1080\/07391102.2020.1845980","volume":"40","author":"M Rajendran","year":"2022","unstructured":"Rajendran M, Roy S, Ravichandran K, Mishra B, Gupta DK, Nagarajan S, Arul Selvaraj RC, Provaznik I (2022) In silico screening and molecular dynamics of phytochemicals from Indian cuisine against SARS-CoV-2 MPro. J Biomol Struct Dyn 40(7):3155\u20133169. https:\/\/doi.org\/10.1080\/07391102.2020.1845980","journal-title":"J Biomol Struct Dyn"},{"issue":"5","key":"10621_CR47","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s10930-013-9492-3","volume":"32","author":"CB Jalkute","year":"2013","unstructured":"Jalkute CB, Barage SH, Dhanavade MJ, Sonawane KD (2013) Molecular dynamics simulation and molecular docking studies of angiotensin converting enzyme with inhibitor lisinopril and amyloid beta peptide. Protein J 32(5):356\u2013364. https:\/\/doi.org\/10.1007\/s10930-013-9492-3","journal-title":"Protein J"},{"issue":"8","key":"10621_CR48","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s10930-013-9492-3","volume":"36","author":"F Azam","year":"2018","unstructured":"Azam F, Alabdullah NH, Ehmedat HM, Abulifa AR, Taban I, Upadhyayula S (2018) NSAIDs as potential treatment option for preventing amyloid \u03b2 toxicity in Alzheimer\u2019s disease: An investigation by docking, molecular dynamics, and DFT studies. J Biomol Struct Dyn 36(8):2099\u20132117. https:\/\/doi.org\/10.1007\/s10930-013-9492-3","journal-title":"J Biomol Struct Dyn"},{"issue":"8","key":"10621_CR49","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1021\/acs.molpharmaceut.9b00250","volume":"16","author":"G Gocheva","year":"2019","unstructured":"Gocheva G, Ivanova A (2019) A look at receptor-ligand pairs for active-targeting drug delivery from crystallographic and molecular dynamics perspectives. Mol Pharm 16(8):3293\u20133321. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00250","journal-title":"Mol Pharm"},{"key":"10621_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/2046-1682-5-2","author":"H Qin","year":"2012","unstructured":"Qin H, Lim L, Song J (2012) Protein dynamics at Eph receptor-ligand interfaces as revealed by crystallography, NMR and MD simulations. BMC Biophys. https:\/\/doi.org\/10.1186\/2046-1682-5-2","journal-title":"BMC Biophys"},{"key":"10621_CR51","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1039\/C3MB70271E","volume":"9","author":"V Bhavaniprasand","year":"2013","unstructured":"Bhavaniprasand V, Dass Prabhu JF, Jayanthi S (2013) Activation mechanism of claudin-4 by ephrin type-A receptor 2: a molecular dynamics approach. Mol BioSyst 9:2627\u20132634. https:\/\/doi.org\/10.1039\/C3MB70271E","journal-title":"Mol BioSyst"},{"issue":"17","key":"10621_CR52","doi-asserted-by":"publisher","first-page":"17301","DOI":"10.1074\/jbc.M500363200","volume":"280","author":"M Koolpe","year":"2005","unstructured":"Koolpe M, Burgess R, Dail M, Pasquale EB (2005) EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J Biol Chem 280(17):17301\u201317311","journal-title":"J Biol Chem"},{"key":"10621_CR53","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.2147\/IJN.S69572","volume":"9","author":"FY Chen","year":"2014","unstructured":"Chen FY, Yan JJ (2014) TNYL peptide functional chitosan-g-stearate conjugate micelles for tumor specific targeting 9:4597\u20134608. https:\/\/doi.org\/10.2147\/IJN.S69572","journal-title":"TNYL peptide functional chitosan-g-stearate conjugate micelles for tumor specific targeting"},{"issue":"2","key":"10621_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.str.2005.11.011","volume":"14","author":"JE Chrencik","year":"2005","unstructured":"Chrencik JE, Brooun A, Recht MI, Kraus ML, Koolpe M, Kolatkar AR, Bruce RH, Martiny-Baron G, Widmer H, Pasquale EB, Kuhn P (2005) Structure and thermodynamic characterization of the Ephrin B4\/Ephrin B2 antagonist peptide complex reveals the determinants for receptor specificity. Structure 14(2):321\u2013330. https:\/\/doi.org\/10.1016\/j.str.2005.11.011","journal-title":"Structure"},{"issue":"21","key":"10621_CR55","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.2174\/1381612822666160224143008","volume":"22","author":"VJ Haupt","year":"2016","unstructured":"Haupt VJ, Aguilar JE, Salentin US, Daminelli S, Leonhardt F, Konc J, Schroeder M (2016) Computational drug reposition by target hopping. Curr Pharm Des 22(21):3124\u20133134. https:\/\/doi.org\/10.2174\/1381612822666160224143008","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10621_CR56","doi-asserted-by":"publisher","first-page":"e18128","DOI":"10.1371\/journal.pone.0018128","volume":"6","author":"C Giorgio","year":"2011","unstructured":"Giorgio C, Mohamed IH, Flammini L, Barocelli E, Incerti M, Lodola A, Tognolini M (2011) Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation. 6(3):e18128. https:\/\/doi.org\/10.1371\/journal.pone.0018128","journal-title":"Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation."},{"issue":"1","key":"10621_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/cmdc.201300305","volume":"9","author":"M Tognolini","year":"2014","unstructured":"Tognolini M, Incerti M, Pala D, Russo S, Castelli R, Hassan-Mohamed-I GC, Lodola A (2014) Target-hopping as a useful tool for the identification of novel EphA2 protein-protein antagonists. ChemMedChem 9(1):67\u201372. https:\/\/doi.org\/10.1002\/cmdc.201300305","journal-title":"ChemMedChem"},{"issue":"5","key":"10621_CR58","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.phrs.2011.06.008","volume":"64","author":"IH Mohamed","year":"2011","unstructured":"Mohamed IH, Girogio C, Bruni R, Flammini L, Barocelli E, Rossi D, Domenichini G, Poli F, Tognilini M (2011) Polyphenol rich botanicals used as food supplements interfere with EphA1-ephrin A1 system. Phamacol Res 64(5):464\u2013470. https:\/\/doi.org\/10.1016\/j.phrs.2011.06.008","journal-title":"Phamacol Res"},{"issue":"4","key":"10621_CR59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.phrs.2012.05.010","volume":"66","author":"R Noberini","year":"2012","unstructured":"Noberini R, Koolpe M, Lamberto I, Pasquale EB (2012) Inhibition of Eph receptor-eprhin ligand interaction by tea polyphenols. Pharmacol Res 66(4):363\u2013373. https:\/\/doi.org\/10.1016\/j.phrs.2012.05.010","journal-title":"Pharmacol Res"},{"issue":"10","key":"10621_CR60","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2174\/0929867323666160316123609","volume":"23","author":"M Marcin","year":"2016","unstructured":"Marcin M, Bogdan L (2016) Cinnamic acid derivatives as inhibitors of oncogenic protein kinases \u2013 structure, mechanisms and biomedical effects. Curr Med Chem 23(10):954\u2013982. https:\/\/doi.org\/10.2174\/0929867323666160316123609","journal-title":"Curr Med Chem"},{"key":"10621_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10989-014-9435-7","volume":"21","author":"S Vijayakumar","year":"2015","unstructured":"Vijayakumar S, Lakshmi PTV (2015) ACPP: a web server for prediction and design of anti-cancer peptides. Int J Pept Res Ther 21:99\u2013106. https:\/\/doi.org\/10.1007\/s10989-014-9435-7","journal-title":"Int J Pept Res Ther"},{"key":"10621_CR62","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.1038\/s41388-019-0931-2","volume":"38","author":"L Liang","year":"2019","unstructured":"Liang L, Patel O, Janes PW, Murphy JM, Lucet IS (2019) Eph receptor signaling: from catalytic to non-catalytic functions. Oncogene 38:6567\u20136584. https:\/\/doi.org\/10.1038\/s41388-019-0931-2","journal-title":"Oncogene"},{"issue":"3","key":"10621_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/bib\/bbaa153","volume":"22","author":"P Agarwal","year":"2021","unstructured":"Agarwal P, Bhagat D, Mahalwal M, Sharma N, Raghava GP (2021) AntiCP 2.0: an updated model of predicting anticancer peptides. Brief Bioinform 22(3):153. https:\/\/doi.org\/10.1093\/bib\/bbaa153","journal-title":"Brief Bioinform"},{"issue":"1","key":"10621_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2105-9-40","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinf 9(1):40. https:\/\/doi.org\/10.1186\/1471-2105-9-40","journal-title":"BMC Bioinf"},{"issue":"4","key":"10621_CR65","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5(4):725\u2013738. https:\/\/doi.org\/10.1038\/nprot.2010.5","journal-title":"Nat Protoc"},{"issue":"1","key":"10621_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"J Yang","year":"2015","unstructured":"Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y (2015) The I-TASSER suite: protein structure and function prediction. Nat Methods 12(1):7\u20138. https:\/\/doi.org\/10.1038\/nmeth.3213","journal-title":"Nat Methods"},{"key":"10621_CR67","unstructured":"Schr\u00f6dinger L, DeLano W (2020) PyMOL. Retrieved from http:\/\/www.pymol.org\/pymol"},{"key":"10621_CR68","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jngse.2016.02.007","volume":"30","author":"T Aissaoui","year":"2016","unstructured":"Aissaoui T, AlNashef IM, Benguerba Y (2016) Dehydration of natural gas using choline chloride based deep eutectic solvents: COSMO-RS prediction. J Nat Gas Sci Eng 30:571\u2013577. https:\/\/doi.org\/10.1016\/j.jngse.2016.02.007","journal-title":"J Nat Gas Sci Eng"},{"issue":"39","key":"10621_CR69","doi-asserted-by":"publisher","first-page":"11512","DOI":"10.1021\/jp507547q","volume":"118","author":"M Gonzalez-Miquel","year":"2014","unstructured":"Gonzalez-Miquel M, Massel M, DeSilva A, Palomar J, Rodriguez F, Brennecke JF (2014) Excess enthalpy of monoethanolamine + ionic liquid mixtures: how good are COSMO-RS Predictions? J Phys Chem B 118(39):11512\u201311522. https:\/\/doi.org\/10.1021\/jp507547q","journal-title":"J Phys Chem B"},{"issue":"34","key":"10621_CR70","doi-asserted-by":"publisher","first-page":"17597","DOI":"10.1039\/C4RA01081G","volume":"4","author":"S Mulyono","year":"2014","unstructured":"Mulyono S, Hizaddin HF, Alnashef IM, Hashim MA, Fakeeha AH, Hadj-Kali MK (2014) Separation of BTEX aromatics from n-octane using a (tetrabutylammonium bromide + sulfolane) deep eutectic solvent \u2013 experiments and COSMO-RS prediction. RSC Adv 4(34):17597\u201317606. https:\/\/doi.org\/10.1039\/C4RA01081G","journal-title":"RSC Adv"},{"issue":"16","key":"10621_CR71","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/cmdc.201800398","volume":"13","author":"A Troster","year":"2018","unstructured":"Troster A, Heinzlmeri S, Berger BT, Gande SL, Saxena K, Sreeramulu S, Linhard V, Nasiri A, Bolte M, Muller S, Juster B, Medard G, Kudlinzki D, Schwalbe H (2018) NVP-BHG712: effects of regioisomers on the affinity and selectivity toward the EPHrin family. ChemMedChem 13(16):1629\u20131633. https:\/\/doi.org\/10.1002\/cmdc.201800398","journal-title":"ChemMedChem"},{"issue":"1","key":"10621_CR72","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/bioinformatics\/btp599","volume":"26","author":"J Yu","year":"2010","unstructured":"Yu J, Zhou Y, Tanaka I, Yao M (2010) Roll: a new algorithm for the detection of protein pockets and cavities with a rolling probe sphere. Bioinformatics 26(1):46\u201352. https:\/\/doi.org\/10.1093\/bioinformatics\/btp599","journal-title":"Bioinformatics"},{"issue":"4","key":"10621_CR73","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/omi.2009.0045","volume":"13","author":"B Huang","year":"2009","unstructured":"Huang B (2009) metaPocket: a meta approach to improve protein ligand binding site prediction. OMICS 13(4):325\u2013330. https:\/\/doi.org\/10.1089\/omi.2009.0045","journal-title":"OMICS"},{"issue":"2","key":"10621_CR74","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"issue":"1","key":"10621_CR75","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1038\/s41598-021-82410-1","volume":"11","author":"IA Guedes","year":"2021","unstructured":"Guedes IA, Barreto AMS, Marinho D, Krempser E, Kuenemann MA, Sperandio O, Dardenne LE, Miteva MA (2021) New machine learning and physics-based scoring functions for drug discovery. Sci Rep 11(1):3198. https:\/\/doi.org\/10.1038\/s41598-021-82410-1","journal-title":"Sci Rep"},{"issue":"24","key":"10621_CR76","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ins.2014.08.002","volume":"289","author":"CS de Magalh\u00e3es","year":"2014","unstructured":"de Magalh\u00e3es CS, Almeida DM, Barbosa HJC, Dardenne LE (2014) A dynamic niching genetic algorithm strategy for docking highly flexible ligands. Inf Sci 289(24):206\u2013224. https:\/\/doi.org\/10.1016\/j.ins.2014.08.002","journal-title":"Inf Sci"},{"key":"10621_CR77","doi-asserted-by":"publisher","unstructured":"Sebastian S, Sven S, Joachim HV (2015) Adasme Melissa F, and Schroeder Michael. Plip: fully automated protein\u2013ligand interaction profiler. Nucleic Acids Res 43 (1): 443-447. https:\/\/doi.org\/10.1093\/nar\/gkv315","DOI":"10.1093\/nar\/gkv315"},{"key":"10621_CR78","unstructured":"Maestro, Schr\u00f6dinger, LLC, New York, 2020"},{"key":"10621_CR79","unstructured":"Desmond Molecular Dynamics System, D. E. Shaw Research, New York, 2020."},{"issue":"5","key":"10621_CR80","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10(5):449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"issue":"13","key":"10621_CR81","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1002\/jcc.21859","volume":"32","author":"S Du","year":"2011","unstructured":"Du S, H., Xi, L., Li, J., Yang, Y., Liu, H., Yao, X, (2011) Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime\/MM GBSA calculation. J Comp Chem 32(13):2800\u20132809","journal-title":"J Comp Chem"},{"key":"10621_CR82","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep UK 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep UK"},{"issue":"1","key":"10621_CR83","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A, Chen X, Hou T (2021) ADMETlab2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 49(1):5\u201314","journal-title":"Nucleic Acids Res"},{"key":"10621_CR84","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-60761-670-2_3","volume":"627","author":"MJE Fischer","year":"2010","unstructured":"Fischer MJE (2010) Amine coupling through EDC\/NHS: a practical approach. Methods Mol Biol 627:55\u201373. https:\/\/doi.org\/10.1007\/978-1-60761-670-2_3","journal-title":"Methods Mol Biol"},{"key":"10621_CR85","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00216-014-7647-5","volume":"406","author":"S Mariani","year":"2014","unstructured":"Mariani S, Minunni M (2014) Surface plasmon resonance applications in clinical analysis. Anal Bioanal Chem 406:2303\u20132323. https:\/\/doi.org\/10.1007\/s00216-014-7647-5","journal-title":"Anal Bioanal Chem"},{"issue":"1\u20134","key":"10621_CR86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/s1050-3862(99)00042-x","volume":"16","author":"PS Stayton","year":"1999","unstructured":"Stayton PS, Freitag S, Klumb LA, Chilkoti A, Chu V, Penzotti JE, To R, Hyre D, Le Trong I, Lybrand TP, Stenkamp RE (1999) Streptavidin\u2013biotin binding energetics. Biomol Eng 16(1\u20134):39\u201344. https:\/\/doi.org\/10.1016\/s1050-3862(99)00042-x","journal-title":"Biomol Eng"},{"issue":"6","key":"10621_CR87","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/adt.2009.0222","volume":"7","author":"H Zegzouti","year":"2009","unstructured":"Zegzouti H, Zdanovskaia M, Hsiao K, Goueli SA (2009) ADP-Glo: a bioluminescent and homogeneous ADP monitoring assay for kinases Assay Drug Dev. Technol 7(6):560\u2013572. https:\/\/doi.org\/10.1089\/adt.2009.0222","journal-title":"Technol"},{"key":"10621_CR88","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-4939-7201-2_17","volume":"1647","author":"S Kumar","year":"2017","unstructured":"Kumar S, Li H (2017) In silico design of anticancer peptides. Proteom Drug Discov 1647:245\u2013254. https:\/\/doi.org\/10.1007\/978-1-4939-7201-2_17","journal-title":"Proteom Drug Discov"},{"issue":"10","key":"10621_CR89","doi-asserted-by":"publisher","first-page":"867","DOI":"10.56093\/ijas.v82i10.24178","volume":"82","author":"G Jethra","year":"2012","unstructured":"Jethra G, Mishra AK, Pandey PS, Chandrasekharan H (2012) Structure and function prediction of unknown wheat protein using LOMETS and I-TASSER. Indian J Agr Sci 82(10):867\u2013874","journal-title":"Indian J Agr Sci"},{"issue":"W1","key":"10621_CR90","doi-asserted-by":"publisher","first-page":"W174","DOI":"10.1093\/nar\/gkv342","volume":"43","author":"J Yang","year":"2015","unstructured":"Yang J, Zhang Y (2015) I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res 43(W1):W174\u2013W181. https:\/\/doi.org\/10.1093\/nar\/gkv342","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10621_CR91","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/bioinformatics\/btp650","volume":"26","author":"D Huang","year":"2010","unstructured":"Huang D, Zhou T, Lafleur K, Nevado C, Caflisch A (2010) Kinase selectivity potential inhibitors targeting the ATP binding site: a network analysis. Bioinformatics 26(2):198\u2013204. https:\/\/doi.org\/10.1093\/bioinformatics\/btp650","journal-title":"Bioinformatics"},{"issue":"6","key":"10621_CR92","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/s0092-8674(01)00496-2","volume":"106","author":"LE Wybenga-Groot","year":"2001","unstructured":"Wybenga-Groot LE, Baskin B, Ong SH, Tong J, Pawson T, Sicheri F (2001) Structural basis for autoinhibition of the Eph2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 106(6):745\u2013757. https:\/\/doi.org\/10.1016\/s0092-8674(01)00496-2","journal-title":"Cell"},{"issue":"18","key":"10621_CR93","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.3390\/ijms20184574","volume":"20","author":"PHM Torres","year":"2019","unstructured":"Torres PHM, Sodero ACR, Jofily P, Silvia-Jr FP (2019) Key topics in molecular docking for drug design. Int J Mol Sci 20(18):4574. https:\/\/doi.org\/10.3390\/ijms20184574","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10621_CR94","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1021\/acs.jcim.9b00905","volume":"60","author":"KB Santos","year":"2020","unstructured":"Santos KB, Guedes IA, Karl ALM, Dardenne LE (2020) Highly flexible ligand docking: benchmarking of the DockThor program on the LEADS-PEP protein-peptide data set. J Chem Inf Model 60(2):667\u2013683. https:\/\/doi.org\/10.1021\/acs.jcim.9b00905","journal-title":"J Chem Inf Model"},{"issue":"9","key":"10621_CR95","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1016\/j.bmcl.2008.04.015","volume":"18","author":"C Bardelle","year":"2008","unstructured":"Bardelle C, Cross D, Davenport S, Kettle JG, Ko EJ, Leach AG, Mortlock A, Read J, Roberts NJ, Robins P, Williams EJ (2008) Inhibitors of the tyrosine kinase EphB4 Part I: structure-based design and optimization of a series of 2, 4-bis-anilinopyrimidines. Bioorg Med Chem Lett 18(9):2776\u20132780. https:\/\/doi.org\/10.1016\/j.bmcl.2008.04.015","journal-title":"Bioorg Med Chem Lett"},{"key":"10621_CR96","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12859-020-03643-x","volume":"21","author":"P Durai","year":"2020","unstructured":"Durai P, Ko Y-J, Pan C-H, Park K (2020) Evolutionary chemical binding similarity approach integrated with 3D-QSAR method for effective virtual screening. BMC Bioinf 21:309. https:\/\/doi.org\/10.1186\/s12859-020-03643-x","journal-title":"BMC Bioinf"},{"issue":"1","key":"10621_CR97","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/prot.22028","volume":"73","author":"P Kolb","year":"2008","unstructured":"Kolb P, Kipouros CB, Huang D, Caflisch A (2008) Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors. Proteins 73(1):11\u201318. https:\/\/doi.org\/10.1002\/prot.22028","journal-title":"Proteins"},{"issue":"3","key":"10621_CR98","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0006-291x(89)92780-0","volume":"158","author":"Y Imai","year":"1989","unstructured":"Imai Y, Nakamura M (1989) Point mutations at threonine-301 modify substrate specificity of rabbit liver microsomal cytochromes P-450 (laurate (\u03c9-1)-hydroxylase and testosterone 16\u03b1-hydroxylase). Biochem Bioph Res Co 158(3):717\u2013722. https:\/\/doi.org\/10.1016\/0006-291x(89)92780-0","journal-title":"Biochem Bioph Res Co"},{"issue":"20","key":"10621_CR99","doi-asserted-by":"publisher","first-page":"14831","DOI":"10.1074\/jbc.275.20.14831","volume":"275","author":"AF Kisselev","year":"2000","unstructured":"Kisselev AF, Songyang Z, Goldberg AL (2000) Why does threonine, and not serine, function as the active site nucleophile in proteasomes? J Biol Chem 275(20):14831\u201314837","journal-title":"J Biol Chem"},{"issue":"5","key":"10621_CR100","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/bit.20148","volume":"87","author":"JG Ho","year":"2004","unstructured":"Ho JG, Middelberg AP (2004) Estimating the potential refolding yield of recombinant proteins expressed as inclusion bodies. Biotechnol Bioeng 87(5):584\u2013592. https:\/\/doi.org\/10.1002\/bit.20148","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"10621_CR101","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157(1):105\u2013132. https:\/\/doi.org\/10.1016\/0022-2836(82)90515-0","journal-title":"J Mol Biol"},{"issue":"1","key":"10621_CR102","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1006\/jmbi.2000.4473","volume":"307","author":"M Brandl","year":"2001","unstructured":"Brandl M, Weiss MS, Jabs A, Suhnel J, Hilgenfeld R (2001) C-H\u2014pi-interactions in proteins. J Mol Bio 307(1):357\u2013377. https:\/\/doi.org\/10.1006\/jmbi.2000.4473","journal-title":"J Mol Bio"},{"key":"10621_CR103","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ejmech.2016.01.057","volume":"112","author":"A Unzue","year":"2016","unstructured":"Unzue A, Lafleur K, Zhao H, Zhou T, Dong J, Kolb P, Liebl J, Zahler S, Caflisch A, Nevado C (2016) Three stories on Eph kinase inhibitors: from in silico discovery to in vivo validation. Eur J Med Chem 112:347\u2013366. https:\/\/doi.org\/10.1016\/j.ejmech.2016.01.057","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10621_CR104","doi-asserted-by":"publisher","first-page":"7558","DOI":"10.3390\/molecules20057558","volume":"20","author":"B Fa","year":"2015","unstructured":"Fa B, Cong S, Wang J (2015) Pi-pi stacking mediated cooperative mechanism for human cytochrome P450 3A4. Molecules 20(5):7558\u20137573. https:\/\/doi.org\/10.3390\/molecules20057558","journal-title":"Molecules"},{"issue":"4","key":"10621_CR105","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10822-019-00193-0","volume":"33","author":"H Chen","year":"2019","unstructured":"Chen H, Wang Y, Gao Z, Yang W, Gao J (2019) Assessing the performance of three resveratrol in binding with SIRT1 by molecular dynamics simulation and MM\/GBSA methods: the weakest binding of resveratrol 3 to SIRT1 triggers a possibility of dissociation from its binding site. J Comput Aided Mol Des 33(4):437\u2013446. https:\/\/doi.org\/10.1007\/s10822-019-00193-0","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"10621_CR106","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1517\/17425255.1.2.303","volume":"1","author":"S Ekins","year":"2005","unstructured":"Ekins S, Andreyev S, Ryabov A, Kirillov E, Rakhmatulin EA, Bugrim A, Nikolskaya T (2005) Computational prediction of human drug metabolism. Expert Opin Drug Met 1(2):303\u2013324. https:\/\/doi.org\/10.1517\/17425255.1.2.303","journal-title":"Expert Opin Drug Met"},{"issue":"8","key":"10621_CR107","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/90761","volume":"19","author":"J Hodgson","year":"2001","unstructured":"Hodgson J (2001) ADMET\u2014turning chemicals into drugs. Nat Biotechnol 19(8):722\u2013726. https:\/\/doi.org\/10.1038\/90761","journal-title":"Nat Biotechnol"},{"issue":"15","key":"10621_CR108","doi-asserted-by":"publisher","first-page":"127281","DOI":"10.1016\/j.bmcl.2020.127281","volume":"30","author":"HW El-Shafey","year":"2020","unstructured":"El-Shafey HW, Gomaa RM, El-Messery SM, Goda FE (2020) Quinazoline based hsp90 inhibitors: synthesis, modeling study and adme calculations towards breast cancer targeting. Bioord Med Chem Lett 30(15):127281. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127281","journal-title":"Bioord Med Chem Lett"},{"issue":"2","key":"10621_CR109","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci6003515","volume":"47","author":"T Hou","year":"2007","unstructured":"Hou T, Wang J, Zhang W, Xu X (2007) ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules? J Chem Inf Model 47(2):460\u2013463. https:\/\/doi.org\/10.1021\/ci6003515","journal-title":"J Chem Inf Model"},{"issue":"10","key":"10621_CR110","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.2174\/187152012803833107","volume":"12","author":"Z Yang","year":"2012","unstructured":"Yang Z, Kulkarni K, Zhu W, Hu M (2012) Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME. Anticancer Agents Med Chem 12(10):1264\u20131280. https:\/\/doi.org\/10.2174\/187152012803833107","journal-title":"Anticancer Agents Med Chem"},{"issue":"9","key":"10621_CR111","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1021\/jm0492002","volume":"48","author":"YC Martin","year":"2005","unstructured":"Martin YC (2005) A bioavailability score. J Med Chem 48(9):3164\u20133170. https:\/\/doi.org\/10.1021\/jm0492002","journal-title":"J Med Chem"},{"issue":"12","key":"10621_CR112","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/ci500467k","volume":"54","author":"A Daina","year":"2014","unstructured":"Daina A, Michielin O, Zoete V (2014) iLOGP: a simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach. J Chem Inf Model 54(12):3284\u20133301. https:\/\/doi.org\/10.1021\/ci500467k","journal-title":"J Chem Inf Model"},{"key":"10621_CR113","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jmgm.2015.06.004","volume":"60","author":"T Kim","year":"2015","unstructured":"Kim T, Park H (2015) Computational prediction of octanol\u2013water partition coefficient based on the extended solvent-contact model. J Mol Graph Model 60:108\u2013117. https:\/\/doi.org\/10.1016\/j.jmgm.2015.06.004","journal-title":"J Mol Graph Model"},{"issue":"1","key":"10621_CR114","doi-asserted-by":"publisher","first-page":"100343","DOI":"10.1016\/j.jaim.2020.07.002","volume":"13","author":"AJ Gandhi","year":"2022","unstructured":"Gandhi AJ, Rupareliya JD, Shukla VJ, Donga SB, Acharya R (2022) An ayurvedic perspective along with in silico study of the drugs for the management of Sars-Cov-2. J. Ayurveda Integr. Med. 13(1):100343. https:\/\/doi.org\/10.1016\/j.jaim.2020.07.002","journal-title":"J. Ayurveda Integr. Med."},{"issue":"1\u20132","key":"10621_CR115","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijpharm.2018.07.046","volume":"549","author":"CM Chagas","year":"2018","unstructured":"Chagas CM, Moss S, Alisaraie L (2018) Drug metabolites and their effects on the development of adverse reactions: revisiting Lipinski\u2019s Rule of Five. Int J Pharm 549(1\u20132):133\u2013149. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.07.046","journal-title":"Int J Pharm"},{"issue":"4","key":"10621_CR116","first-page":"80","volume":"35","author":"CL Alfaro","year":"2001","unstructured":"Alfaro CL (2001) Emerging role of drug interaction studies in drug development: the good, the bad, and the unknown. Psychopharmacol Bull 35(4):80\u201393","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"10621_CR117","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejps.2003.07.003","volume":"21","author":"LM Chan","year":"2004","unstructured":"Chan LM, Lowes S, Hirst BH (2004) The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 21(1):25\u201351. https:\/\/doi.org\/10.1016\/j.ejps.2003.07.003","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10621_CR118","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00007691-200002000-00029","volume":"22","author":"Y Tanigawara","year":"2000","unstructured":"Tanigawara Y (2000) Role of P-glycoprotein in drug disposition. Ther Drug Monit 22(1):137\u2013140. https:\/\/doi.org\/10.1097\/00007691-200002000-00029","journal-title":"Ther Drug Monit"},{"key":"10621_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-019-0334-y","author":"T Hanser","year":"2019","unstructured":"Hanser T, Steinmetz FP, Plante J, Rippmann R, Krier M (2019) Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting. J Chemoinformatics. https:\/\/doi.org\/10.1186\/s13321-019-0334-y","journal-title":"J. Chemoinformatics."},{"key":"10621_CR120","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4939-8760-3_12","volume":"1860","author":"RP Sparks","year":"2019","unstructured":"Sparks RP, Jenkins JL, Fratti R (2019) Use of surface plasmon resonance (SPR) to determine binding affinities and kinetic parameters between components important in fusion machinery. Methods Mol Biol 1860:199\u2013210. https:\/\/doi.org\/10.1007\/978-1-4939-8760-3_12","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10621_CR121","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1021\/acs.jcim.5b00150","volume":"55","author":"N Singh","year":"2015","unstructured":"Singh N, Tiwari S, Srivastava KK, Siddiqi MI (2015) Identification of Novel Inhibitors of Mycobacterium tuberculosis PknG Using Pharmacophore Based Virtual Screening. Docking, Molecular Dynamics Simulation, and Their Biological Evaluation 55(6):1120\u20131129. https:\/\/doi.org\/10.1021\/acs.jcim.5b00150","journal-title":"Docking, Molecular Dynamics Simulation, and Their Biological Evaluation"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-023-10621-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:12:14Z","timestamp":1744197134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-023-10621-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":121,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10621"],"URL":"https:\/\/doi.org\/10.1007\/s11030-023-10621-x","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"31 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"NA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors give full consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}